Mercado, Gabriela
Castillo, Valentina
Soto, Paulina
López, Nélida
Axten, Jeffrey M.
Sardi, Sergio P.
Hoozemans, Jeroen J.M.
Hetz, Claudio
Funding for this research was provided by:
FONDECYT (11140738)
Michael J Fox Foundation for Parkinson's Research (9277, 12473)
Millennium Institute (P09-015-F)
FONDAP (15150012)
ALS Therapy Alliance (2014-F-059)
Muscular Dystrophy Association (382453)
FONDEF (ID16I10223)
FONDEF (D11E1007)
FONDECYT (1140549)
ALSRP Therapeutic Idea (AL150111)
US Office of Naval Research-Global (N62909-16-1-2003)
U.S. Air Force Office of Scientific Research (FA9550-16-1-0384)
CONICYT-Brazil (441921/2016-7)
CONICYT
This article is maintained by: Elsevier
Article Title: Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease
Journal Title: Neurobiology of Disease
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nbd.2018.01.004
Content Type: article
Copyright: © 2018 Elsevier Inc. All rights reserved.